J B Chemicals & Pharmaceuticals Ltd.
BSE: 506943 | Sector: Health care |
NSE: JBCHEPHARM | ISIN Code: INE572A01028 |
BSE 00:00 | 22 Mar | 1959.20 |
4.25 (0.22%) |
OPEN
1954.55 |
HIGH
1975.00 |
LOW
1944.05 |
NSE 00:00 | 22 Mar | 1958.05 |
2.55 (0.13%) |
OPEN
1955.40 |
HIGH
1985.00 |
LOW
1943.95 |
OPEN | 1954.55 |
PREVIOUS CLOSE | 1954.95 |
VOLUME | 510 |
52-Week high | 2149.90 |
52-Week low | 1339.05 |
P/E | 39.59 |
Mkt Cap.(Rs cr) | 15,164 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
J B Chemicals & Pharmaceuticals Ltd. (JBCHEPHARM) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
18-09-2020 |
THE VANGUARD GROUP INC A/C VANGUAR D EMERG. MKTS STOCK INDEXFD A SERIES OF V I E I F |
NSE | BUY | 706756 | 1121.89 |
02-11-2017 | ASHISH DHAWAN | NSE | SELL | 472096 | 289.54 |
01-11-2017 | ASHISH DHAWAN | NSE | SELL | 1952206 | 288.12 |
01-11-2017 |
ICICI LOMBARD GENERAL INSURANCE CO LIMITED |
NSE | BUY | 2000000 | 288.00 |
25-10-2017 |
KOTAK MAHINDRA ASSET MANAGEMENT CO LTD (SSV2 -SELL CODE) PM |
NSE | SELL | 600659 | 280.00 |
19-08-2011 |
CROSSEAS CAPITAL SERVICES PVT. LTD. |
NSE | SELL | 460160 | 139.49 |
19-08-2011 |
CROSSEAS CAPITAL SERVICES PVT. LTD. |
NSE | BUY | 460160 | 139.12 |
19-08-2011 |
CROSSEAS CAPITAL SERVICES PRIVATE L IMITED |
BSE | BUY | 459986 | 139.35 |
19-08-2011 |
CROSSEAS CAPITAL SERVICES PRIVATE L IMITED |
BSE | SELL | 459986 | 139.10 |
25-05-2011 | ASHISH DHAWAN | NSE | BUY | 565446 | 128.02 |
01-01-2008 | JMP SECURITIES PVT. LTD. | BSE | BUY | 428175 | 97.44 |
Quick Links for J B Chemicals & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices